Skip to main content

Table 5 Associations between the SNPs and hepatotoxicity and dyslipidemia

From: Impact of IL6R genetic variants on treatment efficacy and toxicity response to sarilumab in rheumatoid arthritis

SNPs

Genotype (n)

Hepatotoxicity

Dyslipidemia

  

%

Genetic model

p

%

Genetic model

p

rs4845625

T/T (9)

33.3

Cod

0.07

44.4

Cod

0.14

C/T (28)

7.1

Dom

0.027

35.7

Rec

0.056

C/C (25)

4

  

16

  

rs11265618

T/T (42)

14.3

Cod

0.08

23.8

Cod

0.41

C/T (17)

0

Dom

0.026

41.2

Dom

0.19

C/C (3)

0

  

33.3

  

rs4329505

T/T (42)

14.3

Cod

0.08

23.8

Cod

0.41

C/T (17)

0

Dom

0.026

41.2

Dom

0.19

C/C (3)

0

  

33.3

  

rs2228145

A/A (22)

13.6

Cod

0.75

50

Cod

0.028

C/A (27)

7.4

Dom

0.44

5

Dom

0.008

C/C (13)

7.7

  

2

  

rs4537545

C/C (20)

15

Cod

0.64

50

Cod

0.046

C/T (28)

7.1

Dom

0.34

17.9

Dom

0.014

T/T (14)

7.1

  

21.4

  
  1. Abbreviations: SNPs Single Nucleotide Polymorphisms, p p-value